Proposed Changes to 340B May Curb Hospital Abuses
Outpatient branded drug sales in the 340B Drug Pricing Program now amount to almost 8% of the total market, well up from 5.4% in 2012, according to a whitepaper from the Berkeley Research Group.1
Continue reading on ONCLive